Oversee business development and sales process for medical isotopes produced at McMaster Nuclear Reactor. Focus on I-125, Ho-166 and Lu-177 markets. Utilize advanced analytics to uncover market insights and manage sales processes.

Member of the board of directors, overseeing technical and scientific aspects of company development.

•Developed strategy for clinical trials of hypoxia PET tracers•Prepared regulatory submissions: IND; meeting package, white paper•Performed in vivo validation of novel PET tracers•Studied PET tracer metabolism in rodents•Acquired and analyzed PET images using experimental tracers•Studied tumor micro environment in rodent models (oxygen electrodes)•Developed new methods for QC of radiopharmaceuticals

•Qualified new protocols for clinical production of PET tracers•Designed new automated radiochemistry instruments•Led field tests of automated radiochemistry units•Performed Quality Control of radiopharmaceuticals: HPLC, GC, Pyrogens•Synthesized PET tracers using experimental automated modules•Contributed to regulatory submissions (CMC)•Wrote SOPs, Master Formulas

•Developed PET agents for tumor microenvironment (acidiosis)•Performed in vivo small animal PET imaging•Studied cell-association profile of the synthesized imaging agent•Developed peptide based PET agent for imaging of tumor acidity•Introduced new conjugation method for peptide radiolabeling.•Synthesized and radiolabeled peptides up to 35 amino acid long•Synthesized bifunctional chelating agents for peptide labeling

•Developed novel macromolecular probes for oxygen imaging in vivo •Studied tumor microenvironment (hypoxia) in vivo•Developed synthetic methods for dendrimer assembly and modification•Purified and characterized macromolecules: GPC, MALDI•Studied energy and electron transfer in dendritic structures•Synthesized metalloporphyrin dyes and dendrimers based upon them.•Synthesized two chromophore systems: porphyrin - coumarin •Carried out photophysical studies: energy… Show more •Developed novel macromolecular probes for oxygen imaging in vivo •Studied tumor microenvironment (hypoxia) in vivo•Developed synthetic methods for dendrimer assembly and modification•Purified and characterized macromolecules: GPC, MALDI•Studied energy and electron transfer in dendritic structures•Synthesized metalloporphyrin dyes and dendrimers based upon them.•Synthesized two chromophore systems: porphyrin - coumarin •Carried out photophysical studies: energy transfer; two-photon absorption, fluorescence, phosphorescence, quantum yield, emission lifetime Show less

•Led the development of a new type of oscillating catalysts for olefin polymerization.•Participated in collaboration with polymer divisions of Exxon, Total, Borealis.•Developed oscillating olefin polymerization catalysts, with nitrogen substituent at indenyl ring.•Synthesized ansa-metallocenes with bridge from 4'th position of indenyl ligand to cyclopentadienyl ligand.•Introduced non-phosphine catalyst for homocoupling of arylbromides •Optimized Suzuki coupling for synthesis… Show more •Led the development of a new type of oscillating catalysts for olefin polymerization.•Participated in collaboration with polymer divisions of Exxon, Total, Borealis.•Developed oscillating olefin polymerization catalysts, with nitrogen substituent at indenyl ring.•Synthesized ansa-metallocenes with bridge from 4'th position of indenyl ligand to cyclopentadienyl ligand.•Introduced non-phosphine catalyst for homocoupling of arylbromides •Optimized Suzuki coupling for synthesis of 4-aryl substituted ansa- zirconocenes.•Synthesized first example of single-atom nitrogen-bridged ansa-metallocenes. Show less

• Performed complex synthetic procedures, up to 12 steps• Characterized small molecules using : HPLC, GC-MS, LCMS, NMR• Developed new methods for amine vynilation• Followed protocols for synthesis of organic/organometallic precursors• Synthesized hydrazone-based libraries of small molecules• Synthesized building blocks for screening libraries:heterocyclic compounds, non-natural amino acids